THE HEIL COMPANY – Trademark Portfolio
Entity Type: 03
THE HEIL COMPANY holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 12 (Vehicles) — 18 filings in this category. The portfolio also extends into Class 7 (Machinery) across 5 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include HEIL, PYTHON, DURAPACK, HALF/PACK, and MULTIPACK. The owner is based in Chattanooga, TN.
Suite 200
2030 Hamilton Place Blvd
Chattanooga, TN 37421
Showing of trademarks Trademarks
Trademark Classifications
THE HEIL COMPANY's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Machines and machine tools; motors and engines; machine coupling and transmission components
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does THE HEIL COMPANY have?
THE HEIL COMPANY has 22 U.S. trademarks filed with the USPTO. Of these, 8 registered, 2 abandoned, 12 cancelled.
What trademark classes does THE HEIL COMPANY file in?
THE HEIL COMPANY files trademarks across 5 Nice Classification classes. The most active classes are Class 12 (Vehicles), Class 7 (Machinery), Class 37 (Building & Construction), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 12 covers vehicles; apparatus for locomotion by land, air or water.
What are THE HEIL COMPANY's most well-known trademarks?
THE HEIL COMPANY's registered trademark portfolio includes well-known marks such as HEIL, PYTHON, DURAPACK, HALF/PACK, and MULTIPACK. These are among 8 currently registered trademarks in the portfolio.
What is THE HEIL COMPANY's trademark registration success rate?
THE HEIL COMPANY has a 36% trademark registration rate, with 8 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.